These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8384346)

  • 1. Hypercalcemia with calcium carbonate for uraemic hyperparathyroidism: consequence of a challenge overmet by the nephrologist?
    Fournier A
    Nephrol Dial Transplant; 1993; 8(2):188-9. PubMed ID: 8384346
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of metabolic bone disease in patients on peritoneal dialysis.
    Armstrong A; Cunningham J
    Kidney Int Suppl; 1994 Dec; 48():S51-7. PubMed ID: 7700042
    [No Abstract]   [Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
    Parsons V; Baldwin D; Moniz C; Marsden J; Ball E; Rifkin I
    Nephron; 1993; 63(4):379-83. PubMed ID: 8459870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary hyperparathyroidism in uraemic patients on chronic haemodialysis--a case report and review.
    Lim YK
    Singapore Med J; 1973 Jun; 14(2):99-103. PubMed ID: 4741441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypercalcemia due to oral calcium carbonate in chronic hemodialysed patients. Measurement of plasma parathyroid hormone and gastrin].
    Fournier A; Ferrière C; Guéris J; Sebert JL; Bordler P; Quichaud J
    J Urol Nephrol (Paris); 1976; 82(4-5):371-2. PubMed ID: 940186
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of hypercalcaemia in haemodialysis patients.
    Pascual N; Andrea C; Zaleski M; Hernandez J; Goicoechea M
    EDTNA ERCA J; 1997; 23(3):48-50. PubMed ID: 9664010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uremic pruritus].
    Cohen EP
    Nephrologie; 1993; 14(5):215-9. PubMed ID: 8159250
    [No Abstract]   [Full Text] [Related]  

  • 9. Milk-alkali syndrome with metastatic calcification.
    Goldsmith DJ
    Am J Med; 1996 Apr; 100(4):481-2. PubMed ID: 8610740
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of disturbed calcium metabolism in uraemic patients: 2. Indications for parathyroidectomy.
    Schömig M; Ritz E
    Nephrol Dial Transplant; 2000; 15 Suppl 5():25-9. PubMed ID: 11073271
    [No Abstract]   [Full Text] [Related]  

  • 11. Low prevalence of hypercalcemia in Korean dialysis patients: possible role of dietary phosphate intake.
    Park MS; Kim JH; Lee HB
    Perit Dial Int; 1999; 19(3):270-3. PubMed ID: 10433166
    [No Abstract]   [Full Text] [Related]  

  • 12. [2 dialysis cases which came to our clinic for the symptoms caused by hypercalcemia].
    Shin J; Nishioka M; Shinko S; Yamamoto T; Shibuya K; Kasumoto H; Bito Y; Fujita Y; Komaba K
    Clin Calcium; 2005 Sep; 15 Suppl 1():87-91; discussion 91. PubMed ID: 16272638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of correcting hyperphosphatemia in chronic renal failure and in dialysis (review)].
    Novikov AI
    Ter Arkh; 1997; 69(12):63-7. PubMed ID: 9503540
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parathyroid and bone. Secondary hyperparathyroidism after renal transplantation].
    Negi S; Okamoto M; Shigematsu T
    Clin Calcium; 2007 Dec; 17(12):1880-7. PubMed ID: 18057664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of calcium carbonate in dialysis patients with hypercalcemia.
    Verhelst JA; Van den Enden EJ; Zachée P; Daelemans RA; Lins RL
    Clin Nephrol; 1988 Nov; 30(5):287. PubMed ID: 3214973
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiopathic hypercalcaemia of chronic dialysis.
    Feest TG; Newrick P; Read DJ
    Proc Eur Dial Transplant Assoc; 1983; 19():248-52. PubMed ID: 6348738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems of dialysis in transplant patients.
    Sadler JH
    Transplant Proc; 1972 Dec; 4(4):571-4. PubMed ID: 4566798
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.
    Fournier A; Moriniere P; Sebert JL; Dkhissi H; Atik A; Leflon P; Renaud H; Gueris J; Gregoire I; Idrissi A
    Kidney Int Suppl; 1986 Feb; 18():S114-9. PubMed ID: 3457987
    [No Abstract]   [Full Text] [Related]  

  • 19. Iatrogenic hypercalcemia in hemodialysis patients in spite of the use of low dialysate calcium.
    Goicoechea M; Pascual N; Zaleski M; Andrea C; Hernández J; de Sequera P
    Clin Nephrol; 1997 Jul; 48(1):67-8. PubMed ID: 9247790
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.